| 1 |
27098147 | Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest. | 2016 |
1 |
| 2 |
19270508 | Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed. | 2009 May |
1 |
| 3 |
16204068 | Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer. | 2005 Oct 1 |
6 |
| 4 |
12802789 | The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells. | 2003 Jun |
3 |
| 5 |
11980662 | The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates. | 2002 May 1 |
1 |
| 6 |
11448931 | The impact of p53 status on cellular sensitivity to antifolate drugs. | 2001 Jul |
1 |
| 7 |
10785598 | Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed. | 2000 May |
2 |
| 8 |
9106628 | p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex). | 1997 Apr |
2 |
| 9 |
8840989 | DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. | 1996 Oct 15 |
1 |